JPS6350332B2 - - Google Patents

Info

Publication number
JPS6350332B2
JPS6350332B2 JP54144561A JP14456179A JPS6350332B2 JP S6350332 B2 JPS6350332 B2 JP S6350332B2 JP 54144561 A JP54144561 A JP 54144561A JP 14456179 A JP14456179 A JP 14456179A JP S6350332 B2 JPS6350332 B2 JP S6350332B2
Authority
JP
Japan
Prior art keywords
detergent
solution
neisseria meningitidis
minutes
sodium desoxycholate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54144561A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5566519A (en
Inventor
Beruteiru Heruteingu Torusuten
Guteerurain Geruharuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of JPS5566519A publication Critical patent/JPS5566519A/ja
Publication of JPS6350332B2 publication Critical patent/JPS6350332B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP14456179A 1978-11-11 1979-11-09 Manufacture of membrane protein and vaccine containing it Granted JPS5566519A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782848965 DE2848965A1 (de) 1978-11-11 1978-11-11 Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine

Publications (2)

Publication Number Publication Date
JPS5566519A JPS5566519A (en) 1980-05-20
JPS6350332B2 true JPS6350332B2 (cg-RX-API-DMAC7.html) 1988-10-07

Family

ID=6054405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14456179A Granted JPS5566519A (en) 1978-11-11 1979-11-09 Manufacture of membrane protein and vaccine containing it

Country Status (9)

Country Link
EP (1) EP0011243B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5566519A (cg-RX-API-DMAC7.html)
AT (1) ATE857T1 (cg-RX-API-DMAC7.html)
AU (1) AU533386B2 (cg-RX-API-DMAC7.html)
CA (1) CA1142083A (cg-RX-API-DMAC7.html)
DE (2) DE2848965A1 (cg-RX-API-DMAC7.html)
DK (1) DK154841C (cg-RX-API-DMAC7.html)
ES (1) ES485715A1 (cg-RX-API-DMAC7.html)
IL (1) IL58673A (cg-RX-API-DMAC7.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317811A (en) 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
JPH074267B1 (cg-RX-API-DMAC7.html) * 1982-12-02 1995-01-25 Univ Rockefeller
US7118757B1 (en) 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
BR9910749A (pt) 1998-05-29 2001-02-13 Chiron Corp Composições e vacinas imunogênicas combinadas para meningites b e c e método de induzir uma resposta imune por administração da mesma
NZ528254A (en) 1999-05-19 2005-07-29 Chiron S Combined neisserial compositions
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
US8273360B2 (en) 2000-01-17 2012-09-25 Novartis Ag Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
GB0103171D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
DK2255826T3 (en) 2002-08-02 2016-06-20 Glaxosmithkline Biologicals Sa Neisserial vaccine compositions comprising a combination of antigens.
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
CU23313A1 (es) 2002-11-27 2008-09-25 Inst Finlay Ct De Investigacia Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
EP1706481A2 (en) * 2003-12-23 2006-10-04 GlaxoSmithKline Biologicals S.A. Vaccine
GB0419627D0 (en) 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
ES2390291T3 (es) 2006-06-12 2012-11-08 Glaxosmithkline Biologicals S.A. Vacunas LOS L3V
NZ584683A (en) 2007-10-19 2012-05-25 Novartis Ag Neisseria meningitidis serogroup B vaccine formulations
ES2532946T3 (es) 2008-02-21 2015-04-06 Novartis Ag Polipéptidos PUfH meningocócicos
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
CA2747340A1 (en) 2008-12-17 2010-06-24 Novartis Ag Meningococcal vaccines including hemoglobin receptor
AU2010258677B2 (en) 2009-06-10 2016-10-06 Glaxosmithkline Biologicals S.A. Benzonaphthyridine-containing vaccines
JP2013502918A (ja) 2009-08-27 2013-01-31 ノバルティス アーゲー 髄膜炎菌ｆＨＢＰ配列を含むハイブリッドポリペプチド
JP2013503148A (ja) 2009-08-27 2013-01-31 ノバルティス アーゲー アルミニウム、オリゴヌクレオチドおよびポリカチオンを含むアジュバント
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
CN102724988B (zh) 2009-09-30 2014-09-10 诺华股份有限公司 脑膜炎球菌fHBP多肽的表达
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
CA2784580A1 (en) 2009-12-15 2011-07-14 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
CA2792683A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Neisserial fhbp vaccine composition
AU2011288203A1 (en) 2010-03-18 2012-08-23 Novartis Ag Adjuvanted vaccines for serogroup B meningococcus
CA2792938C (en) 2010-03-23 2018-07-31 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
US9259462B2 (en) 2010-09-10 2016-02-16 Glaxosmithkline Biologicals Sa Developments in meningococcal outer membrane vesicles
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
US20150147356A1 (en) 2011-05-12 2015-05-28 Alan Kimura Antipyretics to enhance tolerability of vesicle-based vaccines
WO2013113917A1 (en) 2012-02-02 2013-08-08 Novartis Ag Promoters for increased protein expression in meningococcus
US10598666B2 (en) 2012-03-08 2020-03-24 Glaxosmithkline Biologicals Sa In vitro potency assay for protein-based meningococcal vaccines
JP2015521595A (ja) 2012-06-14 2015-07-30 ノバルティス アーゲー 血清群ｘ髄膜炎菌のためのワクチン
RU2015106930A (ru) 2012-09-06 2016-10-20 Новартис Аг Комбинированные вакцины с менингококком серогруппы в и к/д/с
US9764027B2 (en) 2012-09-18 2017-09-19 Glaxosmithkline Biologicals Sa Outer membrane vesicles
US10392424B2 (en) 2014-02-28 2019-08-27 Glaxosmithkline Biologicals Sa Modified meningococcal fHbp polypeptides
AU2017321039B2 (en) 2016-09-02 2021-03-18 Glaxosmithkline Biologicals Sa Vaccines for Neisseria gonorrhoeae
EP3678693A1 (en) 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Bacterial extracellular vesicles
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
KR102852282B1 (ko) 2018-11-06 2025-09-01 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
EP3799884A1 (en) 2019-10-01 2021-04-07 GlaxoSmithKline Biologicals S.A. Immunogenic compositions
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202115072D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202211033D0 (en) 2022-07-28 2022-09-14 Glaxosmithkline Biologicals Sa Purification process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.BACTEVIOL=1978 *

Also Published As

Publication number Publication date
CA1142083A (en) 1983-03-01
DE2848965A1 (de) 1980-05-22
DK154841B (da) 1988-12-27
EP0011243B1 (de) 1982-04-14
EP0011243A1 (de) 1980-05-28
DE2962526D1 (en) 1982-05-27
IL58673A (en) 1983-02-23
ATE857T1 (de) 1982-04-15
AU533386B2 (en) 1983-11-24
IL58673A0 (en) 1980-02-29
DK475779A (da) 1980-05-12
ES485715A1 (es) 1980-05-16
AU5268279A (en) 1980-05-15
DK154841C (da) 1989-06-05
JPS5566519A (en) 1980-05-20

Similar Documents

Publication Publication Date Title
JPS6350332B2 (cg-RX-API-DMAC7.html)
US4271147A (en) Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
JP4827196B2 (ja) 髄膜炎菌類タンパク質ｎｍｂ１８７０のドメインおよびエピトープ
US6355253B1 (en) Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci
US4220717A (en) Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
JP5960055B2 (ja) 改変髄膜炎菌ｆＨＢＰポリペプチド
RU2475496C2 (ru) МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHBP
US9707286B2 (en) Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium
JP2015110653A (ja) 髄膜炎菌ｆＨＢＰ配列を含むハイブリッドポリペプチド
KR102779223B1 (ko) 변형된 수막구균 fhbp 폴리펩티드
KR102626831B1 (ko) 수막구균 백신
JPH09500538A (ja) ナイセリア・メニンギチジス外膜グループｂポーリンタンパク質の高レベル発現、精製および再生
JPS61186400A (ja) 細菌由来中性多糖類と免疫原性タン白との安定な、共有結合された多糖―タンパク質結合体、該結合体の製造方法並びに該結合体を含む医薬組成物
US4196192A (en) Combined Haemophilus influenzae type b and pertussis vaccine
Holland et al. Evidence for in vivo expression of transferrin-binding proteins in Haemophilus influenzae type b
JPH03502881A (ja) 淋菌ｐｉタンパク質およびワクチンの製造
KR20220070279A (ko) 면역원성 조성물
EP0400569B1 (en) Method for preparing a vaccine from Streptococcus mutans for dental caries and vaccinal compositions for dental caries used as nasal drops
CN110891597B (zh) 防治家禽滑膜霉浆菌感染的组合物
JPS5852227A (ja) 淋菌からの免疫原性複合体
CN113354742A (zh) 一种布鲁氏杆菌基因工程亚单位疫苗及其制备方法和应用
JP2889923B2 (ja) 百日咳トキソイドワクチン
RU2407792C1 (ru) СПОСОБ ПОЛУЧЕНИЯ IgAl-ПРОТЕАЗЫ ИЗ КУЛЬТУРЫ NEISSERIA MENINGITIDIS СЕРОГРУППЫ А И ИММУНОГЕННЫЙ ПРЕПАРАТ НА ЕЕ ОСНОВЕ
NZ188211A (en) Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
RU2296560C2 (ru) Суппозитории для иммунопрофилактики вирусных инфекций